Ute Amann
Overview
Explore the profile of Ute Amann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
406
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Steinbrech J, Amann U, Irlbeck M, Clauss S, Strobach D
J Clin Med
. 2025 Jan;
14(2).
PMID: 39860345
: QTc prolongation can result in lethal arrhythmia. Risk scores like the Tisdale score can be used for risk stratification for targeted pharmaceutical interventions. However, the practical usability across different...
2.
Gessele C, Remi C, Smolka V, Dimitriadis K, Amann U, Saller T, et al.
Drugs Aging
. 2025 Jan;
42(2):177-178.
PMID: 39812939
No abstract available.
3.
Gessele C, Remi C, Smolka V, Dimitriadis K, Amann U, Saller T, et al.
Drugs Aging
. 2024 Nov;
41(12):1003-1013.
PMID: 39607472
Purpose: Postoperative delirium (POD) is a common complication in older adult patients after surgery. A patient's preoperative anticholinergic (AC) burden is a potentially modifiable risk factor for POD. As the...
4.
Strobach D, Chiriac U, Klausner S, Krebs S, Langebrake C, Querbach C, et al.
Pharmacy (Basel)
. 2024 Jul;
12(4).
PMID: 39051393
Drug information (DI) provided by hospital pharmacies aims to promote rational and safe drug therapy. While quality assessment for this task is recommended, more knowledge on the factors determining the...
5.
Gessele C, Saller T, Smolka V, Dimitriadis K, Amann U, Strobach D
BMC Geriatr
. 2024 May;
24(1):422.
PMID: 38741037
Background: Postoperative delirium (POD) is the most common complication following surgery in elderly patients. During pharmacist-led medication reconciliation (PhMR), a predictive risk score considering delirium risk-increasing drugs and other available...
6.
Voss A, Kollhorst B, Platzbecker K, Amann U, Haug U
Clin Epidemiol
. 2023 Jul;
15:827-837.
PMID: 37483262
Purpose: Over the last decade, the use of direct oral anticoagulants (DOACs) has strongly increased. We aimed to describe and compare risk profiles including potential changes over time among persons...
7.
Amann U, Wentzell N, Kollhorst B, Haug U
Reprod Toxicol
. 2023 May;
119:108415.
PMID: 37245698
Use of endothelin receptor antagonists (ERAs) and riociguat, approved for treatment of pulmonary hypertension (PH), is contraindicated during pregnancy due to reported teratogenicity in animals. We aimed to investigate prescribing...
8.
Nolde M, Ahn N, Dreischulte T, Krause E, Guntner F, Gunter A, et al.
Eur J Intern Med
. 2022 Oct;
106:80-89.
PMID: 36195531
Background And Aims: Observational research has indicated that proton pump inhibitors (PPIs) might increase the long-term risk of cardiovascular events. This study evaluated the evidence from observational studies for an...
9.
Ahn N, Nolde M, Gunter A, Guntner F, Gerlach R, Tauscher M, et al.
Eur J Neurol
. 2022 Feb;
29(5):1335-1343.
PMID: 35170158
Background And Purpose: Understanding the adverse effects of proton pump inhibitors (PPIs) is important due to their widespread use, but the available evidence for an increased dementia risk amongst patients...
10.
Nolde M, Ahn N, Dreischulte T, Ruckert-Eheberg I, Guntner F, Gunter A, et al.
Aliment Pharmacol Ther
. 2021 Dec;
55(1):141-142.
PMID: 34907568
No abstract available.